,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,87030,16686,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,328,1,1,,87030,16686,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,1469,1,1,,29217887,16686,Inconclusive,189491771.0,7068.0,70.7946,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
3,1479,1,2,,29217887,16686,Active,189491771.0,7068.0,31.6228,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
4,1490,2,1,,29217887,16686,Inconclusive,10954339.0,,17.7828,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
5,1766,1,1,,29217887,16686,Inconclusive,18860839.0,4221.0,3.1623,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
6,1766,1,1,,29217887,16686,Inconclusive,56550039.0,4297.0,3.1623,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
7,1768,1,1,,29217887,16686,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
8,1768,1,1,,29217887,16686,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
9,2101,1,1,,29217887,16686,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
10,2107,1,1,,29217887,16686,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
11,2112,1,1,,29217887,16686,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
12,2314,1,2,,29217887,16686,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
13,2314,1,2,,29217887,16686,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
14,2315,1,2,,29217887,16686,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
15,2315,1,2,,29217887,16686,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
16,2451,1,2,,29217887,16686,Inconclusive,122920737.0,,17.7407,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
17,2472,1,2,,29217887,16686,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
18,2517,2,1,,29217887,16686,Active,6980812.0,,11.2202,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
19,2528,1,2,,29217887,16686,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
20,2546,1,1,,29217887,16686,Active,188536040.0,19885.0,7.0795,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
21,2549,1,1,,29217887,16686,Inconclusive,282403581.0,,31.6228,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
22,2551,1,1,,29217887,16686,Active,188536040.0,19885.0,8.9125,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
23,485281,1,1,,29217887,16686,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
24,485290,1,1,,29217887,16686,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
25,504327,1,1,,29217887,16686,Inconclusive,153791535.0,2648.0,39.8107,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
26,504847,1,1,,29217887,16686,Active,63054845.0,7421.0,3.1623,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
27,588579,1,1,,29217887,16686,Active,7705344.0,51426.0,6.7016,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
28,602332,1,1,,29217887,16686,Inconclusive,168984549.0,,2.5119,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
29,720532,1,1,,29217887,16686,Active,420597.0,,3.1623,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
30,720533,1,1,,29217887,16686,Inconclusive,,,3.5481,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
31,1104375,1,1,,194182387,16686,Unspecified,,,,,"Toxicity against worker Bombus terrestris (bumblebee) assessed as reduction in reproduction at 500 mg a.i./l, po administered through pollen for 11 weeks measured once a week for 11 weeks",Other,20309850.0,
32,1104386,1,1,,194182387,16686,Active,,,,,"Toxicity against worker Bombus terrestris (bumblebee) assessed as reduction in reproduction at 500 mg a.i./l, po administered through sugar water for 11 weeks measured once a week for 11 weeks relative to control",Other,20309850.0,
33,1104410,1,1,,194182387,16686,Inactive,,,,,Contact toxicity against worker Bombus terrestris (bumblebee) assessed as reduction in reproduction at 500 mg a.i./l applied on the dorsal thorax for 11 weeks measured once a week for 11 weeks relative to control,Other,20309850.0,
34,1104433,1,1,,194182387,16686,Inactive,,,,,"Toxicity against worker Bombus terrestris (bumblebee) assessed as mortality at 500 mg a.i./l, po administered through pollen for 11 weeks measured everyday for 3 days followed by once a week for 11 weeks",Other,20309850.0,
35,1104455,1,1,,194182387,16686,Unspecified,,,,,"Toxicity against worker Bombus terrestris (bumblebee) assessed as mortality at 500 mg a.i./l, po administered through sugar water for 11 weeks measured everyday for 3 days followed by once a week for 11 weeks",Other,20309850.0,
36,1104481,1,1,,194182387,16686,Unspecified,,,,,Contact toxicity against worker Bombus terrestris (bumblebee) assessed as mortality at 500 mg a.i./l applied on the dorsal thorax for 11 weeks measured everyday for 3 days followed by once a week for 11 weeks,Other,20309850.0,
37,1259407,1,1,,363907059,16686,Active,,,,,CCRIS mutagenicity studies,Other,,
